← FDA DRUG APPROVALS

FDA ANDA · ANDA088335

THIORIDAZINE HYDROCHLORIDE

Sponsor: MYLAN

APPLICATION
ANDA088335
TYPE
ANDA
LATEST ACTION
1984-04-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

THIORIDAZINE HYDROCHLORIDEDiscontinued
THIORIDAZINE HYDROCHLORIDE 100MG · TABLET · ORAL

Approval history

1984-04-16Manufacturing (CMC) · Supplement 4AP
1984-04-16Manufacturing (CMC) · Supplement 3AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →